Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06096220Phase 4Enrolling by invitation
Phase 4, randomised trial of fluorouracil 5% cream in Odontogenic keratocyst (OKC) (2 arms), sponsored by University of Belgrade. Primary endpoint: Recurrence rate at 5 years. Started Jun 2023; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06096220.